Proprietary Algorithm to Predict Likelihood of FDA Approval
I founded a company that is developing a proprietary algorithm that predicts likelihood of FDA approval based on public clinical data and other factors. We're interviewing hundreds of physicians, biostatisticians and former regulatory professionals to make the algorithm as precise as possible and the results we're getting are very encouraging.
I was wondering how valuable would the probabilities of FDA approval generated by this algorithms be to hedge funds and other institutional investors?
I am thinking of setting it up as subscription service where subscribers would receive on a weekly basis the probabilities generated by the algorithm for all upcoming FDA decisions for a given time range.
How much would HFs be willing to pay (after a 1-month free trial) for this subscription service?